Alkermes (ALKS) Interest Coverage Ratio (QoQ) (2011 - 2026)
Alkermes (ALKS) Interest Coverage Ratio (QoQ) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.08 Bn | 39.43 Bn | 2.15 Bn |
| 3 | Zoetis | 31.54 Bn | 29.87 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.12 Bn | 19.46 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - |
| 10 | Alkermes | 8.09 Bn | 7.43 Bn | 397.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 137.98% |
| Mar 31, 2026 | -108.82% |
| Dec 31, 2025 | -86.19% |
| Sep 30, 2025 | -4.19% |
| Jun 30, 2025 | 548.22% |
| Mar 31, 2025 | 109.60% |
| Dec 31, 2024 | -429.26% |
| Sep 30, 2024 | -5.43% |
| Jun 30, 2024 | 154.83% |
| Mar 31, 2024 | -4.52% |
| Dec 31, 2023 | -48.91% |
| Sep 30, 2023 | -69.99% |
| Jun 30, 2023 | 2,484.92% |
| Mar 31, 2023 | -108.56% |
| Dec 31, 2022 | 279.87% |
| Sep 30, 2022 | -75.99% |
| Jun 30, 2022 | -26.73% |
| Mar 31, 2022 | 94.02% |
| Dec 31, 2021 | -2,161.15% |
| Sep 30, 2021 | -544.67% |